Eye Health Supplement

Preservision AREDS 2

968 adverse event reports submitted to the FDA · 2011–2025 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 968 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Macular degeneration

118

Age-related macular degeneration

Condition aggravated

Foreign body

Dysphagia

Choking

Visual impairment

Diarrhoea

Cataract

Blood pressure increased

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Other Serious or Important Medical Event	823
Hospitalization	120
Visited a Health Care Provider	88
Death	51
Visited Emergency Room	16
Other Outcome	12
Disability	10
Life Threatening	7
Other Serious Outcome	7
Required Intervention	2
Allergic Reaction	2

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

50–64

65–79

228

80+

397

Unknown

312

656 reports had age data; 312 unknown.

Gender

Male

294

Female

657

Unknown/Not Reported

Reports by Year

Annual report counts from 2011–2025. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Hover bars for exact counts.

← View all PreserVision AREDS 2 products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology